Safety and Efficacy of Lacosamide as Additional Therapy in Patients Suffering From Epileptic Tonic-Clonic Seizures
Public ClinicalTrials.gov record NCT02408549. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label, Multicenter Extension Study to Evaluate the Long-term Safety and Efficacy of Lacosamide as Adjunctive Therapy for Uncontrolled Primary Generalized Tonic-Clonic Seizures in Subjects With Idiopathic Generalized Epilepsy
Study identification
- NCT ID
- NCT02408549
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- UCB BIOSCIENCES, Inc.
- Industry
- Enrollment
- 239 participants
Conditions and interventions
Conditions
Interventions
- Lacosamide Oral Solution Drug
- Lacosamide Tablet Drug
Drug
Eligibility (public fields only)
- Age range
- 4 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2, 2015
- Primary completion
- Mar 29, 2023
- Completion
- Mar 29, 2023
- Last update posted
- Dec 13, 2023
2015 – 2023
United States locations
- U.S. sites
- 16
- U.S. states
- 11
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| EP0012 5 | Little Rock | Arkansas | 72205 | — |
| EP0012 8 | Santa Monica | California | 90404 | — |
| Ep0012 31 | Colorado Springs | Colorado | 80907 | — |
| Ep0012 42 | Loxahatchee Groves | Florida | 33470 | — |
| Ep0012 13 | Panama City | Florida | 32405 | — |
| EP0012 2 | Port Charlotte | Florida | 33952 | — |
| Ep0012 15 | Boise | Idaho | 83702 | — |
| Ep0012 21 | Peoria | Illinois | 61637 | — |
| Ep0012 25 | Golden Valley | Minnesota | 55422 | — |
| Ep0012 43 | New York | New York | 10016 | — |
| Ep0012 53 | Austin | Texas | 78758 | — |
| Ep0012 50 | Greenville | Texas | 75401 | — |
| Ep0012 34 | Houston | Texas | 77005 | — |
| Ep0012 38 | San Antonio | Texas | 78229 | — |
| Ep0012 27 | Renton | Washington | 98057 | — |
| Ep0012 23 | Madison | Wisconsin | 53715 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 71 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02408549, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 13, 2023 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02408549 live on ClinicalTrials.gov.